Jan interviews Lisa Diggles to discuss insulin glargine and the introduction of Optisulin and Semglee onto PBS. The learning objectives for this podcast will be: Understand the difference between a second brand and a biosimilar medication. Identify how this PBS change may impact people with diabetes who are on insulin glargine.If you or your clients have questions, simply call 1800 2 SIMPLE (1800 2 746 753) and speak to a CDE.